Home › Funds › Analyst IMS Investment Management Services Ltd. › TEVA

Analyst IMS Investment Management Services Ltd. position in TEVA

TEVA PHARMACEUTICAL INDS LTD · Health Care

Analyst IMS Investment Management Services Ltd. reported holding 2,116,302 shares of TEVA (TEVA PHARMACEUTICAL INDS LTD) in its Q3 2026 13F filing — a position valued at US$83.8M, representing 1.93% of its reported portfolio and ranking #7 among its reported holdings. Analyst IMS Investment Management Services Ltd. has disclosed TEVA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)2.12M sh
Reported value held$83.81M
Portfolio Weight1.93%
First reportedQ4 2025
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Analyst IMS Investment Management Services Ltd.'s TEVA position evolved

Analyst IMS Investment Management Services Ltd. first disclosed a stake in TEVA in Q4 2025 at 2,116,302 shares (US$66.0M). The position peaked in Q3 2026 at 2,116,302 shares, worth US$83.8M. Across 4 filings, Analyst IMS Investment Management Services Ltd. held the position steady without any share-count change. The most recent filing (Q3 2026) shows 2,116,302 shares valued at US$83.8M.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 2.12M $66.05M New
Q1 2026 2.12M $63.74M Hold
Q2 2026 2.12M $71.70M Hold
Q3 2026 2.12M $83.81M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TEVA and 13F data

TEVA (TEVA PHARMACEUTICAL INDS LTD) is a Health Care company. 47 other funds we track also report a position in TEVA — the largest reported positions include BANK OF MONTREAL /CAN/ (US$4.53B), Phoenix Financial Ltd. (US$1.69B), WCM INVESTMENT MANAGEMENT, LLC (US$1.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TEVA

All TEVA fund holders →

FAQ

How long has Analyst IMS Investment Management Services Ltd. held TEVA?

Analyst IMS Investment Management Services Ltd. has disclosed TEVA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Analyst IMS Investment Management Services Ltd.'s current position in TEVA?

As of Q3 2026, Analyst IMS Investment Management Services Ltd. holds 2.12M shares of TEVA (TEVA PHARMACEUTICAL INDS LTD), valued at $83.81M, representing 1.93% of its reported portfolio and ranking #7.

Has Analyst IMS Investment Management Services Ltd. been buying or selling TEVA?

In the latest 13F filing (Q3 2026), Analyst IMS Investment Management Services Ltd. held unchanged its position in TEVA. The position peaked in Q3 2026 at 2.12M shares.

Which other funds hold TEVA?

Other major institutional holders of TEVA include BANK OF MONTREAL /CAN/, Phoenix Financial Ltd., WCM INVESTMENT MANAGEMENT, LLC, among 47 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.